| De novo discovery of traits co-occurring with chronic obstructive pulmonary disease E Golovina, T Fadason, RK Jaros, H Kumar, J John, K Burrowes, ... Life Science Alliance 6 (3), 2023 | 10 | 2023 |
| Pulmonary vessel volume in idiopathic pulmonary fibrosis compared with healthy controls aged> 50 years J John, AR Clark, H Kumar, AC Vandal, KS Burrowes, ML Wilsher, ... Scientific reports 13 (1), 4422, 2023 | 3 | 2023 |
| Lung Shape in IPF Is Different from Healthy Controls, and Is Associated with Extent of Fibrosis J John, AR Clark, H Kumar, KS Burrowes, BJ Bartholmai, R Karworski, ... B36. Spectrum of fibrotic interstitial lung diseases, A2732-A2732, 2022 | 1 | 2022 |
| Quantitative Analysis of Lung Shape in Idiopathic Pulmonary Fibrosis: Insights Into Disease-and Age-Associated Patterns J John, AR Clark, H Kumar, KS Burrowes, AC Vandal, ML Wilsher, ... Academic radiology, 2024 | | 2024 |
| Evaluating Tissue Heterogeneity in the Radiologically Normal-Appearing Tissue in IPF Compared to Healthy Controls J John, AR Clark, H Kumar, KS Burrowes, AC Vandal, ML Wilsher, ... Academic radiology 31 (4), 1676-1685, 2024 | | 2024 |
| Pulmonary Vessel Volume Using a Connected Graph-Based Approach in IPF and Healthy Controls J John, AR Clark, H Kumar, KS Burrowes, BJ Bartholmai, DL Levin, ... B22. EMERGING MANAGEMENT OF FIBROTIC ILDs, A2425-A2425, 2022 | | 2022 |
| A Multiscale Quantitative Comparison of the Normal Lung and Idiopathic Pulmonary Fibrosis J John PhD Thesis-University of Auckland, 2022 | | 2022 |
| Imaging-Based Tissue Heterogeneity to Predict Disease Extent in IPF J John, AR Clark, H Kumar, BJ Bartholmai, DL Levin, C King, ML Wilsher, ... A23. ILD PROGNOSIS AND BIOMARKERS I, A1082-A1082, 2020 | | 2020 |
